Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2012 | Activation of tyrosine phosphatase SHP-1 determines the apoptotic effect of sorafenib on HCC cells. | Tai, W-T.; Shiau, C-W.; Cheng, A-L.; Chen, P-J.; Chen, K-F.; 陳昆鋒; 陳培哲 | Mol. Biol. Cell | | | |
2016 | Lenalidomide as second-line therapy for advanced hepatocellular carcinoma (HCC): biomarker exploration | Shao, Y-Y.; Chen, B-B.; Lin, Z-Z.; Hsu, C-H.; Wang, M-J.; Cheng, A-L.; Hsu, C.; 邵幼雲; 鄭安理; 陳邦斌; 徐志宏 | Annals of Oncology | 0 | 1 | |
2016 | Pembrolizumab in patients with previously treated advanced hepatocellular carcinoma: Phase 2 KEYNOTE-224 study | Zhu, A.; Knox, J.; Kudo, M.; Chan, S.; Finn, R.; Siegel, A.; Ma, J.; Watson, P. A.; Cheng, A-L.; 鄭安理 | Annals of Oncology | 0 | 2 | |